When science and politics collide: Enhancing the FDA-Reference-Cited by-同舟云学术

When science and politics collide: Enhancing the FDA

Published:2019-05-17 Issue:6441 Volume:364 Page:628-631
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Adashi Eli Y.¹,Rajan Rohit S.²,Cohen I. Glenn²³

Affiliation:

1. The Warren Alpert Medical School, Brown University, Providence, RI, USA.

2. Harvard Law School, Harvard University, Cambridge, MA, USA.

3. Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, MA, USA.

Abstract

Science-based decisions on drug safety are threatened by political interference

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference13 articles.

1. R. M. Califf ., Health Aff. (Millwood) 38, 84 (2019). doi:10.1377/hlthaff.2018.05185.

2. The Aspen Institute Health Medicine and Society Program “Seven Former FDA Commissioners Recommend: FDA Should Be an Independent Agency” (2019); https://assets.aspeninstitute.org/content/uploads/2018/10/FDA-Independence-White-Paper-Aspen-Institute-1.pdf?_ga=2.216265238.1677144880.1547315515-1050839834.1547315515E.

3. R. D. Lyons “F.D.A. Shake-up will start with naming of new chief ” The New York Times 10 December 1969; www.nytimes.com/1969/12/10/archives/fda-shakeup-will-start-with-naming-of-new-chief.html.

4. M. Specter “New freedom for the FDA commissioner?” The Washington Post 9 February 1988; www.washingtonpost.com/archive/politics/1988/02/09/new-freedom-for-the-fda-commissioner/3452bfa6-c1d7-48b2-a962-70b7fa98ec7a/?utm_term=.7e162a849614.

5. M. Gladwell “Breaking bureaucratic grip on FDA: Is independence the Answer?” The Washington Post 17 July 1990; www.washingtonpost.com/archive/politics/1990/07/17/breaking-bureaucratic-grip-on-fda-is-independence-the-answer/ae56814a-73ad-4130-9cde-8b220070afdc/?utm_term=.391bbf1cbebf.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Checks and Balances on FDA’s Authority;JAMA;2024-09-03

2. Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process;Journal of Health Politics, Policy and Law;2023-03-24

3. Salud postpandemia: influencia supranacional y coordinación regulatoria;International Journal of Constitutional Law;2022-10-01

4. A “Best Choice Medicine” (BCM) Route to Drug Development to Solve the Aging-Associated Non-Communicable Disease Burden;Journal of Biomedical and Allied Research;2022-06-06

5. Corporate lobbying and product recalls: an investigation in the U.S. medical device industry;Journal of the Academy of Marketing Science;2022-05-05